Clinical trial
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty: A Randomized Controlled Clinical Trial in Diabetic Patients With Below the Knee Critical Limb Ischemia
NCT02915796 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty: A Randomized Controlled Clinical Trial in Diabetic Patients With Below the Knee Critical Limb Ischemia
- Lead sponsor
- Shanghai 10th People's Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 30, 2016
- Completion date
- April 30, 2018
- Enrollment
- 345 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.